Palisade Bio, Inc. (NASDAQ:PALI) Short Interest Up 166.1% in November
Palisade Bio, Inc. (NASDAQ:PALI – Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 114,700 shares, a growth of 166.1% from the October 31st total of 43,100 shares. Currently, 8.8% of the company’s shares are short sold. […]
More Stories
Gilead Sciences’ (GILD) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada
Gilead Sciences (NASDAQ:GILD – Get Free Report)‘s stock had its “sector perform” rating reissued by equities researchers at Royal Bank...
IQVIA’s (IQV) Outperform Rating Reaffirmed at Royal Bank of Canada
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “outperform” rating reiterated by Royal Bank of Canada in a research...
TD Private Client Wealth LLC Cuts Stock Position in Vanguard Growth ETF (NYSEARCA:VUG)
TD Private Client Wealth LLC trimmed its position in shares of Vanguard Growth ETF (NYSEARCA:VUG – Free Report) by 1.7%...
Stifel Nicolaus Issues Positive Forecast for Latham Group (NASDAQ:SWIM) Stock Price
Latham Group (NASDAQ:SWIM – Get Free Report) had its price objective boosted by stock analysts at Stifel Nicolaus from $7.70...
Unigestion Holding SA Raises Stake in PepsiCo, Inc. (NASDAQ:PEP)
Unigestion Holding SA raised its holdings in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 39.0% during the third...
Albertsons Companies Target of Unusually Large Options Trading (NYSE:ACI)
Albertsons Companies, Inc. (NYSE:ACI – Get Free Report) was the target of some unusual options trading on Wednesday. Investors bought...